Sara Khaksar

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Christopher Parker, Nicholas D. James, Chris Brawley et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Urology +13

Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy

Bleddyn Jones, Roger Dale, P Finst et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 79 citations

Medicine, Oncology, Radiation Oncology +14

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study

Martin Boegemann, Sara Khaksar, G. Béra et al. · BMC Cancer · 2019 · 43 citations · Full text

Medicine, Oncology, Urology +15

Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer

Stephen Langley, Ricardo Soares, Jennifer Uribe et al. · British Journal of Urology · 2017 · 36 citations · Full text

Medicine, Oncology, Urology +17